New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 13, 2014
07:53 EDTCRMECardiome's Brinavess shows positive results in cardiological study
Cardiome announced that an independent, investigator-led investigation demonstrated real-world cardioversion experience with Brinavess RINAVESS (vernakalant IV) in patients who developed post-cardiac surgery atrial fibrillation. This was a prospective, non-randomised, single-arm study in 50 patients. The primary outcome was the conversion of atrial fibrillation to sinus rhythm 90 minutes post-Brinavess RINAVESS infusion. Brinavess was successful in cardioverting 74% of the patients.
News For CRME From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 27, 2016
08:11 EDTCRMECardiome announces filing of orphan drug application for oral Vernakalant
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use